https://www.worldpharmatoday.com/research-insight/eu-study-shows-once-daily-lisdexamfetamine-dimesylate-ldx-effective-for-symptom-control-in-children-and-adolescents-with-adhd/ Magazine for the C-level Pharma Executives Thu, 20 Oct 2011 18:30:00 +0000 hourly 1 https://wordpress.org/?v=7.0.2